M. C. Mendes-Correa

Correlations of CTLA‐4 gene polymorphisms and hepatitis C chronic infection

S. Marui, D. Danilovic, Heverton Zambrini, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.

T. Pilot‐Matias, S. Lari, D. Cohen, 2018, Annals of hepatology.

HBV Carrying Drug-Resistance Mutations in Chronically Infected Treatment-Naive Patients

Marcio K. Oikawa, F. Carrilho, A. Lyra, 2015, Antiviral therapy.

Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co‐infection: Clinically relevant or a diagnostic problem?

J. Rockstroh, F. Torriani, R. Solá, 2007, Journal of medical virology.

Resistance Mutations are Rare among Protease Inhibitor Treatment-Naive Hepatitis C Genotype-1 Patients with or without HIV Coinfection

F. Carrilho, M. Gomes-Gouvêa, M. V. Alvarado-Mora, 2015, Antiviral therapy.

Resistance-Associated Variants in HCV Subtypes 1a and 1b Detected by Ion Torrent Sequencing Platform

F. Carrilho, E. Sabino, M. Gomes-Gouvêa, 2016, Antiviral therapy.

High frequency of lamivudine resistance mutations in Brazilian patients co‐infected with HIV and hepatitis B

R. Sitnik, S. Locarnini, M. Gomes-Gouvêa, 2010, Journal of medical virology.

Genotypic distribution of hepatitis C among hepatitis C and HIV co-infected patients in Brazil

A. Barone, M. Mendes-Corrêa, R. Gianini, 2008, International journal of STD & AIDS.